Abacus Life Q2 2023 Earnings Report $8.09 +0.24 (+3.06%) As of 04/14/2025 04:00 PM Eastern Earnings HistoryForecast Abacus Life EPS ResultsActual EPS$0.13Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AAbacus Life Revenue ResultsActual Revenue$11.38 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AAbacus Life Announcement DetailsQuarterQ2 2023Date8/14/2023TimeN/AConference Call DateMonday, August 14, 2023Conference Call Time9:00AM ETUpcoming EarningsAbacus Life's Q1 2025 earnings is scheduled for Monday, May 12, 2025, with a conference call scheduled on Thursday, May 8, 2025 at 5:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesConference Call AudioConference Call TranscriptPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryABL ProfilePowered by Abacus Life Q2 2023 Earnings Call TranscriptProvided by QuartrAugust 14, 2023 ShareLink copied to clipboard.There are 5 speakers on the call. Operator00:00:00Greetings, and welcome to the Abacus Life Second Quarter 2023 Earnings Call. At this time, all participants are in a listen only mode. A brief question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to introduce to you Garrett Edson of ICR. Operator00:00:25Thank you, Garrett. You may begin. Speaker 100:00:29Good day, ladies and gentlemen. Thank you Speaker 200:00:31for standing by. Abacus Life refers participants Operator00:00:33on this call to the investor Speaker 200:00:44Advocacy Life specifically refers participants to the presentation filed today on Form 8 ks with the SEC to remind listeners that some of the comments today may contain forward looking statements and as such will be subject to risks and uncertainties, which if they materialize, could materially affect results. Forward looking statements include, but are not limited to, avatars, flights, Subject to risks, uncertainties and assumptions, which if they materialize, could materially affect results and such forward looking statements do not guarantee performance and Abacus Life gives such assurances. Abacus Life is under no obligation and expressly disclaims any obligation to update, alter or otherwise revise any forward looking Statements whether as a result of new information, future events or otherwise, except as required by law. In addition, historical data pertaining to the operating results and other I will now turn the call over Jay Jackson, Chief Executive Officer of Abacus Life. Speaker 100:01:50Thank you to everyone listening today for your interest in Abacus, And welcome to our first earnings call as a public company. With me today is our Chief Financial Officer, Bill McCauley. And after our remarks, we'll open it up to your questions. Our strong second quarter results continue to validate Abacus' differentiated business model and further contributes to our long track record of sustainable and profitable growth. In addition to our continued progress, we are very pleased to have successfully completed our public listing post quarter end, a milestone for our long term growth ambitions. Speaker 100:02:25Our proven business model, expert team, wealth of data and innovative Technology positions us well to execute on our strategic initiatives, take advantage of the many exciting opportunities that lie ahead and ultimately create long term value for our shareholders. Since this is our first call as a public company And some of you may be hearing our story for the first time. I wanted to spend a few minutes to walk through our compelling business model, Our value proposition and why we are so excited for the opportunities we see to profitably and sustainably grow our business and deliver shareholder value over the long term. Over the last 19 years, we have built a vertically integrated We are a leader in this space with strong market share in a market with high barriers to entry with a seasoned and strong management team, each of whom has 20 plus years of expertise. Crucially, Abacus already generates solid and growing revenue in a $13,000,000,000,000 market with 19 consecutive years of GAAP profitability and with very attractive margins. Speaker 100:03:43In short, our core business is helping clients understand that a life insurance policy is personal property and selling it for a fair market value is a legitimate, safe viable choice, which helps them create more financial options for their future. Life insurance is often a senior citizen's largest asset and one that can be used to alleviate retirement challenges, but they rarely treat it that way. Instead, most people treat their life insurance like debt, not equity. They have it on the wrong side of their ledger. We aid clients in shifting that mindset to creating value and optionality for themselves. Speaker 100:04:19We operate in a massive and relatively untapped addressable market of over $200,000,000,000 annually, providing us with outsized Long term growth potential. If you take anything away from our remarks today, it should be this. Life insurance is one of the largest markets globally. $13,000,000,000,000 in the United States alone, that's 2.5 times America's residential real estate market, A market where more than 9 out of 10 life insurance policies or 90% will never pay a claim. Institutional investors love our product as it's an asset that has a low correlation to other assets and we also have a very strong institutional investment grade counterparties. Speaker 100:05:01Abacus sits at the heart of the life settlement industry and our highly efficient origination platform drives all of our economics, which we believe Leads to outside growth potential for Abacus and our shareholders. Once we identify potential policies for purchase And we ultimately have them go through our origination platform. We have multiple product offerings to drive top line growth. We can sell the policies directly to our capital providers and book gains. We can place them in our inventory to strategically trade the asset. Speaker 100:05:34In fact, we've traded over $1,000,000,000 in the last 3 years or we can hold the asset on our balance sheet, taking advantage of our asset management portfolio and servicing platform to simply service the assets that remain on our book. Additionally, we can also build separately managed accounts for 3rd party investors and institutions or purchase the policies in our investment funds. We have raised over $40,000,000 in new capital in this product line over the last 6 months and anticipate adding more funds to this product line in the coming year. Along with our origination and asset management platforms, we have a proprietary risk technology platform that which provides additional liquidity through our active portfolio management. So let's turn to the counterparty. Speaker 100:06:29Our policy counterparties are generally High quality investment grade insurance companies, typically 95% of all the carriers in our portfolio have an A rating or better from AM Best. The underlying credit that they issue is the life insurance policy, which sits in the cash stack higher than any senior debt or equity that they issue. Moreover, this product is highly regulated at the point of inflection. In fact, we are unaware of a single life insurance Policy issued that did not pay it mortality due to illiquidity of the carrier. As such, the asset itself is incredibly stable. Speaker 100:07:06We believe the real pain point we are helping to solve is that investors cannot find enough life insurance policies to purchase. In addition to counterparty quality, this is an asset class that has a low correlation to the market as a whole. What do I mean by that? Is that this is an effectively equivalent to a mortality driven 0 coupon bond. It's going to appreciate in value as you get closer to the maturity date regardless of the equity or bond market conditions or volatility. Speaker 100:07:35To simplify, let's assume we buy a contract on an 80 year old male. 3 years later, that gentleman will be 83, which means the contract is that much closer ultimately to the maturity date And you receive an increase in value of the underlying contract as the insurer ages. So not only is it a great counterparty, but the contract also appreciates in value over time regardless of market conditions. Abacus is proudly partnered with over 30 1,000 financial professionals and we continue to drive a majority of our policy origination from this channel. However, our Fastest growing origination channel is our direct to consumer channel. Speaker 100:08:15We are very excited about this channel and the opportunity for long term growth that it offers us. We have been building this channel over several years. What's great about the direct to consumer channel is our ability to directly reach and educate the policy owner in terms of his or own liquidity option. We expect to continue our television and digital campaigns to further expand our market share and drive industry awareness. Along with our marketing initiatives to drive our top line, Our real underlying asset is the wealth of technology we've built and longevity data we've accumulated over the years. Speaker 100:08:52Anchored by years of aggregated data and analytics, Abacus is also a data technology company that uses its proprietary data to drive the decision process to acquire policies and leverages it to complement several other products and processes. We've been a technology innovator within our own industry by building our own underlying insurance and data tables to help us make better investment decisions, Issue new insurance products and innovate the wealth planning industry. We believe our longevity data and technology Managed by our subsidiary Longevity Market Technologies can positively impact several industries. 1st, With our digital origination platform known as the Abacus Marketplace, Abacus Advisors and their clients can have a complete end to end digital purchase We also expect to innovate how life insurance is issued and underwritten at the time of issuance, And we are currently advancing a partnership with a life insurance carrier to issue new lifespan based products. Additionally, We expect to launch innovative investment portfolio allocations for retail investors utilizing Their personal lifespan calculated using agingiq.com, our leading online life expectancy calculator with selfie and facial analytics technology. Speaker 100:10:15This would allow investors to use their personal lifespan as a primary driver of portfolio allocation. With respect to our processes, we've invested significantly to have a better understanding of risk and how to properly and quickly measure it on these contracts. We've built our proprietary risk rating platform, which measures risk similar to a risk related FICO score. This risk score is based on several factors, Including duration and extension risk, which we measure against the future carry costs of the contract. We then use our wealth of data to analyze the underlying contract to quickly assess where the contract is and to ultimately drive Abacus' purchase and valuation process. Speaker 100:10:58Additionally, we use our proprietary data analytics to increase origination and awareness by creating what we call our instant policy value calculator. This is an easy to use online tool where we only need 4 pieces of data: gender, age, face value and policy type to generate an instant indicative policy valuation that we provide to advisors and consumers so that they can quickly access the current value of their policy. Offering this data and educating consumers will help us bridge the gap on this with a significant tailwind driven by efforts to educate clients about the value of their policies. Our industry currently only has about 2% market penetration of a $200,000,000,000 plus opportunity with a significant financial incentive to the seniors selling their policy. That's a massive gap that is in our wheelhouse. Speaker 100:12:01We are confident we can close this gap as Abacus sits at the heart of this industry. Our financial metrics illustrate this benefit. We have generated consistent growth year over year, specifically in origination capital deployment, net earnings and return on equity that has continued into 2023 As we delivered once again on growth and profitability in the second quarter, which Bill will touch on in a second, we've reviewed our historical trends. We've thoughtfully evaluated expected origination growth, looked at our revenue streams and corresponding expenses to operate this business and prudently applied it to our public company. With that, I will now hand it over to our CFO, Bill McAuley to discuss the specifics on our Q2 results and financials. Speaker 300:12:50Thanks, Jay, and hello, everyone. As Jay mentioned, we delivered another strong quarter of growth and profitability across our business. While we were not yet public and merged into our current entity during the Q2, I will discuss 2nd quarter results pro form a as if we were, as this will provide you the best apples to apples comparison moving forward. The key driver of our business performance is our highly efficient origination platform. In the Q2 2023, Origination capital deployed increased by approximately 88 percent to $59,700,000 compared to $31,900,000 in the prior period, driven by larger face value policy acquisitions, while maintaining a 4% growth in policy originations to 141 compared to 135 in the prior year period. Speaker 300:13:42Total revenue in the Q2 of 2023 grew by 30% to $18,300,000 compared to $14,100,000 in the prior period. This increase was primarily due to strong performance in our management segment as we deployed more capital to drive growth and originations. Active management revenue increased by approximately 38% to $11,000,000 compared to $8,000,000 in the prior year period. The increase was primarily attributable to maturities of policies accounted for under the investment As of June 30, 2023, Abacus holds 167 policies, of which 121 are accounted for under the fair value method and 46 are accounted for using the investment method, which is cost plus premiums paid. Policies recorded under the investment method represent those policies purchased by Abacus with the intent to sell within the next 12 months. Speaker 300:14:43Revenue from our portfolio of servicing segment was $400,000 which is roughly comparable to the prior year period. Turning to expenses, total operating expenses, Excluding unrealized gains and losses and change in fair value, for the Q2 of 2023 were approximately $4,300,000 compared to $4,600,000 in the prior year period. Adjusted EBITDA for the quarter grew by approximately 33% to $8,800,000 compared to $6,600,000 in the prior year period. The increase was primarily attributable to the strong revenue growth. Adjusted EBITDA margin improved 140 basis points to 48.4% for the quarter compared to 47 in the prior year period. Speaker 300:15:37Net income increased by approximately 40% to 6,400,000 compared to $4,600,000 in the prior year period, driven by strong top line performance and managing costs efficiently. Now focusing our attention to our balance sheet metrics. On an annualized basis, return on equity And return on invested capital for the 3 month period ended June 30, 2023 were 16% and 28.5 percent respectively, reflecting our highly profitable business model. As of June 30, 2023, the company had cash and cash equivalents of $20,600,000 Balance sheet policy assets of $66,500,000 and outstanding long term debt at fair value of $66,200,000 In summary, we are very pleased with our strong results this quarter and we continue to deliver double digit growth on both the top and bottom lines. While we are not currently providing specific guidance, we are excited about the growth opportunities ahead and we are very well positioned to execute on our long term plans. Speaker 300:16:50Also note that in the coming days, we will be releasing our 2022 Quarterly income statement numbers for your reference. I will now turn it back to our CEO, Jay Jackson for our closing comments. Speaker 100:17:03Thanks, Bill. To sum up, we believe Abacus Life is extremely well positioned to capitalize on a massive market opportunity A $200,000,000,000 target market that we expect to see increase every year in new growth verticals led by our longevity data and technology. We are proud to be a growth company that has generated consistent profitability and we expect to continue doing so over the long term, creating value for our shareholders. I'd like to thank all of you for joining us today and we appreciate your interest in Abacus Life. We will now field any questions. Operator00:17:52Thank you. We will now be conducting a question and answer session. One moment please while we poll for questions. One moment please while we poll for questions. And the first question comes from the line of Jim Marrow with Caledigm. Operator00:18:53Please proceed with your question. Speaker 400:18:56Yes. Thanks. Jake, could you dig in a little bit more on the data that you talked about and How that plays a role in the industry and how you can use the data you're collecting over time? Speaker 100:19:09Sure. Thank you, Jim. And the data we've aggregated, if data is the new gold rush, we're standing on a mountain of it. And the reason why over the last 19 years, we've been aggregating data in relationship to medical files and lifespan data per policyholder that we acquire these policies from. And what we've been able to do now is consider how we utilize this data to make not only our process more efficient, because most importantly, We want to make this a strong benefit to the consumer, meaning that if we can make our process more efficient and then we can provide this data back to them, how else could it be used? Speaker 100:19:44Here's a quick example. We built a program called Med Scout. What Med Scout does is, is that when we go and retrieve medical files, which can be From several physicians, several 100 pages long, this will reorganize that entire med file, put it in chronological order with the physicians, And then it would utilize AI technology and actually pull all that data and scan and read it and then give you probability of diagnosis as well as OCD codes for that person. In our current business, where that applies is, is that now we can underwrite a case in literally minutes instead of what would take an individual hours to read and sift through. And now you take that data and you say, okay, how could this apply to, let's say, the healthcare industry and utilizing this type of speed of access to information. Speaker 100:20:32If you're a physician, you're sitting in an emergency room, you can quickly diagnose someone and click on that Simple link of that diagnosis, which is probability of diagnosis and immediately identify in 500 pages of medical files where that diagnosis exists, how many times and what's the And then we take that lifespan data because we aggregate the medical files, interpret that into someone's new projected lifespan and bring that really into personal finance, where we'll be rolling out very shortly how you utilize lifespan in financial planning, specifically around really Innovating how target date funds are utilized today where each person could literally have their own target date fund based upon their lifespan and data. As we use the data initially to build on our current programs, all the way down to now, our next program will be where there's a massive industry in the life Tracking business, we do that to track insurers and policyholders once we acquire and own the policy, utilizing Med And then lastly, in the financial services industry, which we'll be talking about shortly, how you can personalize someone's financial plan specifically related to their lifespan. And that data is going to add into different verticals, but more importantly or even more so add to our currently core business of being able to understand and underwrite our own policyholders even better. Speaker 400:22:05Great. Thanks, Jay. Operator00:22:17A confirmation tone will indicate that your line is in the queue. The next question comes from the line of David Bastian with Kingdom Capital Advisors. Please proceed with your question. Speaker 400:22:29Hey, guys. Thanks for taking my question. I was curious if you could comment on the recent Significant increase in interest rates and how you guys are able to stay profitable despite what I've had shown to be pretty significant Decreases in the discounted future cash flows on your policies? Speaker 100:22:48Sure. Thank you for asking that. Our industry itself is essentially uncorrelated as an investment in the sense that it's a mortality driven contract and not affected by movements in relation to fixed income or equity. However, where interest rates can in fact impact us is in relationship to our own cost of capital and it speaks to why we went public in the first place to help mitigate some of that risk. Being public gives us the opportunity to over the long term lower our capital costs so that we can manage that more effectively. Speaker 100:23:22And What we see today is and I think that this is such an important piece to our business. We do sit at the heartbeat of our industry. What does that really mean? We're effectively the market And we originate new contracts every month to the tune of $15,000,000 to $20,000,000 per month of new capital that we could deploy. And that was reflective in our 2nd quarter results. Speaker 100:23:42When we talk about the growth of 88% on capital deployed, that's what we saw quarter over quarter. So a high interest rate environment, from our perspective actually puts us in a little bit of a sweet spot. Here's why. Policyholders in this environment are seeking liquidity. And now they're coming to us and understanding that their life insurance policy is an effective liquid option now for them that they maybe didn't realize before, so our originations go up. Speaker 100:24:09And in addition to that, as an alternative asset manager within our own portfolio, Being that it's an uncorrelated asset, essentially, there are significant amounts of institutional Capital that is trying to access this asset to get double digit type of discount rates and returns even in this interest rate environment because the underlying asset So from an interest rate perspective and volatility market perspective, where Abacus sits as the market maker is truly a sweet And I think that's reflective in what our Q2 was like. When you look at the growth in earnings, you look at the growth in net income and you look at the growth of originations. Speaker 400:24:51Got it. That's really helpful. Thank you. And then related to that, you guys have these warrants sitting out here. Do you guys view those as a source of capital that you're hoping to get exercised? Speaker 400:25:01Or are you hopeful that you'd be able to use the terms in there to be able to Speaker 100:25:15Our premise was we wanted to see how let's have a couple of earnings calls, let's get everyone very I think 1st and foremost, it's an education process on who Abacus is, what we do, people understanding this data that we have and how we're applying it to not just life insurance, but other areas. And then from there assess what's the plan of action for the warrants, but either is suitable for us. If assuming that the warrants fall into the money And that rewards the shareholders who have stayed with us in this process, terrific. If there's a plan that makes sense to where we would strategically purchase those or try to Are those off back and buy those off the balance sheet? We will certainly consider that as well. Speaker 100:26:02We're I think in addition to the warrants, we're looking at the float Very, very closely and we realize it and that's the issue with anybody who goes public via a SPAC is that you might have a smaller flow. And so in the same mindset of the warrants, we're thinking about when and how a secondary might look for us in the near future. So for us, it's just a matter of getting our information out first, getting investors very comfortable with our story And then exploring all those options sooner rather than later. Speaker 400:26:35Okay. And so given the market size, Do you feel like if you got the $150,000,000 plus from the warrants that you'd be able to quickly deploy that? Or what kind of time would you be looking at given how much of an increase that would be to your capital base? Speaker 100:26:50Yes, that's a great question. And the answer is yes, we would be able to deploy that very, very quickly. So Again, if you look at the origination capital deployed just in the Q2, keep in mind that that was with our own capital, right? Imagine what we could do with another $100,000,000 or $150,000,000 But if you just look at that number, that means we're deploying arguably about $20,000,000 a month in the second quarter. And so then you can kind of extend that math. Speaker 100:27:14If we stayed at that pace, right, which I think that we would probably increase that, but even at that pace, would take us less than 6 months to get that deployed. And what you touch on is something super important that everybody should understand. Where does that what's our use of funds for that? It's to buy this asset, right? We're not here trying to hire more employees and to do these things and to put into this growth model that doesn't produce revenue or income. Speaker 100:27:38We're going to put it right back into the asset that we're buying and put those assets on our balance sheet, right, effectively owning policies. And I think that should be music to your ears And how we deploy that capital, what it would be used for, which would ultimately lead to the growth of our business and company, grow revenues, grow income. Speaker 400:27:57Yes, that makes sense. Thank you so much. Operator00:28:03There are no further questions at this And now I'd like to turn the floor back over to Jay Jackson for any closing comments. Speaker 100:28:10Well, thank you again to everyone for taking the time to listen in today. We are Excited to continue to share our story and our story that has 19 consecutive years of positive net income, Terrific, ROIC, great ROE, and we're a growth company with a massive addressable market that we're just beginning to tap into With data and technology that gives us the opportunity to tap into these other verticals that you're going to start to see over the next 6 months and we'll continue to make this Easier and easier to tell for you, your investors and as investors and shareholders, we thank you for joining this journey with us. And we the 2nd quarter results, we're very excited about and we look forward to future earnings calls with you.Read moreRemove AdsPowered by Conference Call Audio Live Call not available Earnings Conference CallAbacus Life Q2 202300:00 / 00:00Speed:1x1.25x1.5x2xRemove Ads Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Abacus Life Earnings HeadlinesB. Riley Predicts Abacus Life's Q1 Earnings (NASDAQ:ABL)April 11, 2025 | americanbankingnews.comAbacus Life, Inc. (ABL) Soars 6.9%: Is Further Upside Left in the Stock?April 10, 2025 | msn.comNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. April 15, 2025 | Porter & Company (Ad)Piper Sandler Issues Pessimistic Forecast for Abacus Life (NASDAQ:ABL) Stock PriceApril 10, 2025 | americanbankingnews.comAbacus Global price target lowered to $11.50 from $13 at Piper SandlerApril 9, 2025 | markets.businessinsider.comPiper Sandler Reaffirms Their Buy Rating on Abacus Life (ABL)April 8, 2025 | markets.businessinsider.comSee More Abacus Life Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Abacus Life? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Abacus Life and other key companies, straight to your email. Email Address About Abacus LifeAbacus Life (NASDAQ:ABL) operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.View Abacus Life ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Upcoming Earnings ASML (4/16/2025)CSX (4/16/2025)Abbott Laboratories (4/16/2025)Kinder Morgan (4/16/2025)Prologis (4/16/2025)Travelers Companies (4/16/2025)U.S. Bancorp (4/16/2025)Netflix (4/17/2025)American Express (4/17/2025)Blackstone (4/17/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
There are 5 speakers on the call. Operator00:00:00Greetings, and welcome to the Abacus Life Second Quarter 2023 Earnings Call. At this time, all participants are in a listen only mode. A brief question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to introduce to you Garrett Edson of ICR. Operator00:00:25Thank you, Garrett. You may begin. Speaker 100:00:29Good day, ladies and gentlemen. Thank you Speaker 200:00:31for standing by. Abacus Life refers participants Operator00:00:33on this call to the investor Speaker 200:00:44Advocacy Life specifically refers participants to the presentation filed today on Form 8 ks with the SEC to remind listeners that some of the comments today may contain forward looking statements and as such will be subject to risks and uncertainties, which if they materialize, could materially affect results. Forward looking statements include, but are not limited to, avatars, flights, Subject to risks, uncertainties and assumptions, which if they materialize, could materially affect results and such forward looking statements do not guarantee performance and Abacus Life gives such assurances. Abacus Life is under no obligation and expressly disclaims any obligation to update, alter or otherwise revise any forward looking Statements whether as a result of new information, future events or otherwise, except as required by law. In addition, historical data pertaining to the operating results and other I will now turn the call over Jay Jackson, Chief Executive Officer of Abacus Life. Speaker 100:01:50Thank you to everyone listening today for your interest in Abacus, And welcome to our first earnings call as a public company. With me today is our Chief Financial Officer, Bill McCauley. And after our remarks, we'll open it up to your questions. Our strong second quarter results continue to validate Abacus' differentiated business model and further contributes to our long track record of sustainable and profitable growth. In addition to our continued progress, we are very pleased to have successfully completed our public listing post quarter end, a milestone for our long term growth ambitions. Speaker 100:02:25Our proven business model, expert team, wealth of data and innovative Technology positions us well to execute on our strategic initiatives, take advantage of the many exciting opportunities that lie ahead and ultimately create long term value for our shareholders. Since this is our first call as a public company And some of you may be hearing our story for the first time. I wanted to spend a few minutes to walk through our compelling business model, Our value proposition and why we are so excited for the opportunities we see to profitably and sustainably grow our business and deliver shareholder value over the long term. Over the last 19 years, we have built a vertically integrated We are a leader in this space with strong market share in a market with high barriers to entry with a seasoned and strong management team, each of whom has 20 plus years of expertise. Crucially, Abacus already generates solid and growing revenue in a $13,000,000,000,000 market with 19 consecutive years of GAAP profitability and with very attractive margins. Speaker 100:03:43In short, our core business is helping clients understand that a life insurance policy is personal property and selling it for a fair market value is a legitimate, safe viable choice, which helps them create more financial options for their future. Life insurance is often a senior citizen's largest asset and one that can be used to alleviate retirement challenges, but they rarely treat it that way. Instead, most people treat their life insurance like debt, not equity. They have it on the wrong side of their ledger. We aid clients in shifting that mindset to creating value and optionality for themselves. Speaker 100:04:19We operate in a massive and relatively untapped addressable market of over $200,000,000,000 annually, providing us with outsized Long term growth potential. If you take anything away from our remarks today, it should be this. Life insurance is one of the largest markets globally. $13,000,000,000,000 in the United States alone, that's 2.5 times America's residential real estate market, A market where more than 9 out of 10 life insurance policies or 90% will never pay a claim. Institutional investors love our product as it's an asset that has a low correlation to other assets and we also have a very strong institutional investment grade counterparties. Speaker 100:05:01Abacus sits at the heart of the life settlement industry and our highly efficient origination platform drives all of our economics, which we believe Leads to outside growth potential for Abacus and our shareholders. Once we identify potential policies for purchase And we ultimately have them go through our origination platform. We have multiple product offerings to drive top line growth. We can sell the policies directly to our capital providers and book gains. We can place them in our inventory to strategically trade the asset. Speaker 100:05:34In fact, we've traded over $1,000,000,000 in the last 3 years or we can hold the asset on our balance sheet, taking advantage of our asset management portfolio and servicing platform to simply service the assets that remain on our book. Additionally, we can also build separately managed accounts for 3rd party investors and institutions or purchase the policies in our investment funds. We have raised over $40,000,000 in new capital in this product line over the last 6 months and anticipate adding more funds to this product line in the coming year. Along with our origination and asset management platforms, we have a proprietary risk technology platform that which provides additional liquidity through our active portfolio management. So let's turn to the counterparty. Speaker 100:06:29Our policy counterparties are generally High quality investment grade insurance companies, typically 95% of all the carriers in our portfolio have an A rating or better from AM Best. The underlying credit that they issue is the life insurance policy, which sits in the cash stack higher than any senior debt or equity that they issue. Moreover, this product is highly regulated at the point of inflection. In fact, we are unaware of a single life insurance Policy issued that did not pay it mortality due to illiquidity of the carrier. As such, the asset itself is incredibly stable. Speaker 100:07:06We believe the real pain point we are helping to solve is that investors cannot find enough life insurance policies to purchase. In addition to counterparty quality, this is an asset class that has a low correlation to the market as a whole. What do I mean by that? Is that this is an effectively equivalent to a mortality driven 0 coupon bond. It's going to appreciate in value as you get closer to the maturity date regardless of the equity or bond market conditions or volatility. Speaker 100:07:35To simplify, let's assume we buy a contract on an 80 year old male. 3 years later, that gentleman will be 83, which means the contract is that much closer ultimately to the maturity date And you receive an increase in value of the underlying contract as the insurer ages. So not only is it a great counterparty, but the contract also appreciates in value over time regardless of market conditions. Abacus is proudly partnered with over 30 1,000 financial professionals and we continue to drive a majority of our policy origination from this channel. However, our Fastest growing origination channel is our direct to consumer channel. Speaker 100:08:15We are very excited about this channel and the opportunity for long term growth that it offers us. We have been building this channel over several years. What's great about the direct to consumer channel is our ability to directly reach and educate the policy owner in terms of his or own liquidity option. We expect to continue our television and digital campaigns to further expand our market share and drive industry awareness. Along with our marketing initiatives to drive our top line, Our real underlying asset is the wealth of technology we've built and longevity data we've accumulated over the years. Speaker 100:08:52Anchored by years of aggregated data and analytics, Abacus is also a data technology company that uses its proprietary data to drive the decision process to acquire policies and leverages it to complement several other products and processes. We've been a technology innovator within our own industry by building our own underlying insurance and data tables to help us make better investment decisions, Issue new insurance products and innovate the wealth planning industry. We believe our longevity data and technology Managed by our subsidiary Longevity Market Technologies can positively impact several industries. 1st, With our digital origination platform known as the Abacus Marketplace, Abacus Advisors and their clients can have a complete end to end digital purchase We also expect to innovate how life insurance is issued and underwritten at the time of issuance, And we are currently advancing a partnership with a life insurance carrier to issue new lifespan based products. Additionally, We expect to launch innovative investment portfolio allocations for retail investors utilizing Their personal lifespan calculated using agingiq.com, our leading online life expectancy calculator with selfie and facial analytics technology. Speaker 100:10:15This would allow investors to use their personal lifespan as a primary driver of portfolio allocation. With respect to our processes, we've invested significantly to have a better understanding of risk and how to properly and quickly measure it on these contracts. We've built our proprietary risk rating platform, which measures risk similar to a risk related FICO score. This risk score is based on several factors, Including duration and extension risk, which we measure against the future carry costs of the contract. We then use our wealth of data to analyze the underlying contract to quickly assess where the contract is and to ultimately drive Abacus' purchase and valuation process. Speaker 100:10:58Additionally, we use our proprietary data analytics to increase origination and awareness by creating what we call our instant policy value calculator. This is an easy to use online tool where we only need 4 pieces of data: gender, age, face value and policy type to generate an instant indicative policy valuation that we provide to advisors and consumers so that they can quickly access the current value of their policy. Offering this data and educating consumers will help us bridge the gap on this with a significant tailwind driven by efforts to educate clients about the value of their policies. Our industry currently only has about 2% market penetration of a $200,000,000,000 plus opportunity with a significant financial incentive to the seniors selling their policy. That's a massive gap that is in our wheelhouse. Speaker 100:12:01We are confident we can close this gap as Abacus sits at the heart of this industry. Our financial metrics illustrate this benefit. We have generated consistent growth year over year, specifically in origination capital deployment, net earnings and return on equity that has continued into 2023 As we delivered once again on growth and profitability in the second quarter, which Bill will touch on in a second, we've reviewed our historical trends. We've thoughtfully evaluated expected origination growth, looked at our revenue streams and corresponding expenses to operate this business and prudently applied it to our public company. With that, I will now hand it over to our CFO, Bill McAuley to discuss the specifics on our Q2 results and financials. Speaker 300:12:50Thanks, Jay, and hello, everyone. As Jay mentioned, we delivered another strong quarter of growth and profitability across our business. While we were not yet public and merged into our current entity during the Q2, I will discuss 2nd quarter results pro form a as if we were, as this will provide you the best apples to apples comparison moving forward. The key driver of our business performance is our highly efficient origination platform. In the Q2 2023, Origination capital deployed increased by approximately 88 percent to $59,700,000 compared to $31,900,000 in the prior period, driven by larger face value policy acquisitions, while maintaining a 4% growth in policy originations to 141 compared to 135 in the prior year period. Speaker 300:13:42Total revenue in the Q2 of 2023 grew by 30% to $18,300,000 compared to $14,100,000 in the prior period. This increase was primarily due to strong performance in our management segment as we deployed more capital to drive growth and originations. Active management revenue increased by approximately 38% to $11,000,000 compared to $8,000,000 in the prior year period. The increase was primarily attributable to maturities of policies accounted for under the investment As of June 30, 2023, Abacus holds 167 policies, of which 121 are accounted for under the fair value method and 46 are accounted for using the investment method, which is cost plus premiums paid. Policies recorded under the investment method represent those policies purchased by Abacus with the intent to sell within the next 12 months. Speaker 300:14:43Revenue from our portfolio of servicing segment was $400,000 which is roughly comparable to the prior year period. Turning to expenses, total operating expenses, Excluding unrealized gains and losses and change in fair value, for the Q2 of 2023 were approximately $4,300,000 compared to $4,600,000 in the prior year period. Adjusted EBITDA for the quarter grew by approximately 33% to $8,800,000 compared to $6,600,000 in the prior year period. The increase was primarily attributable to the strong revenue growth. Adjusted EBITDA margin improved 140 basis points to 48.4% for the quarter compared to 47 in the prior year period. Speaker 300:15:37Net income increased by approximately 40% to 6,400,000 compared to $4,600,000 in the prior year period, driven by strong top line performance and managing costs efficiently. Now focusing our attention to our balance sheet metrics. On an annualized basis, return on equity And return on invested capital for the 3 month period ended June 30, 2023 were 16% and 28.5 percent respectively, reflecting our highly profitable business model. As of June 30, 2023, the company had cash and cash equivalents of $20,600,000 Balance sheet policy assets of $66,500,000 and outstanding long term debt at fair value of $66,200,000 In summary, we are very pleased with our strong results this quarter and we continue to deliver double digit growth on both the top and bottom lines. While we are not currently providing specific guidance, we are excited about the growth opportunities ahead and we are very well positioned to execute on our long term plans. Speaker 300:16:50Also note that in the coming days, we will be releasing our 2022 Quarterly income statement numbers for your reference. I will now turn it back to our CEO, Jay Jackson for our closing comments. Speaker 100:17:03Thanks, Bill. To sum up, we believe Abacus Life is extremely well positioned to capitalize on a massive market opportunity A $200,000,000,000 target market that we expect to see increase every year in new growth verticals led by our longevity data and technology. We are proud to be a growth company that has generated consistent profitability and we expect to continue doing so over the long term, creating value for our shareholders. I'd like to thank all of you for joining us today and we appreciate your interest in Abacus Life. We will now field any questions. Operator00:17:52Thank you. We will now be conducting a question and answer session. One moment please while we poll for questions. One moment please while we poll for questions. And the first question comes from the line of Jim Marrow with Caledigm. Operator00:18:53Please proceed with your question. Speaker 400:18:56Yes. Thanks. Jake, could you dig in a little bit more on the data that you talked about and How that plays a role in the industry and how you can use the data you're collecting over time? Speaker 100:19:09Sure. Thank you, Jim. And the data we've aggregated, if data is the new gold rush, we're standing on a mountain of it. And the reason why over the last 19 years, we've been aggregating data in relationship to medical files and lifespan data per policyholder that we acquire these policies from. And what we've been able to do now is consider how we utilize this data to make not only our process more efficient, because most importantly, We want to make this a strong benefit to the consumer, meaning that if we can make our process more efficient and then we can provide this data back to them, how else could it be used? Speaker 100:19:44Here's a quick example. We built a program called Med Scout. What Med Scout does is, is that when we go and retrieve medical files, which can be From several physicians, several 100 pages long, this will reorganize that entire med file, put it in chronological order with the physicians, And then it would utilize AI technology and actually pull all that data and scan and read it and then give you probability of diagnosis as well as OCD codes for that person. In our current business, where that applies is, is that now we can underwrite a case in literally minutes instead of what would take an individual hours to read and sift through. And now you take that data and you say, okay, how could this apply to, let's say, the healthcare industry and utilizing this type of speed of access to information. Speaker 100:20:32If you're a physician, you're sitting in an emergency room, you can quickly diagnose someone and click on that Simple link of that diagnosis, which is probability of diagnosis and immediately identify in 500 pages of medical files where that diagnosis exists, how many times and what's the And then we take that lifespan data because we aggregate the medical files, interpret that into someone's new projected lifespan and bring that really into personal finance, where we'll be rolling out very shortly how you utilize lifespan in financial planning, specifically around really Innovating how target date funds are utilized today where each person could literally have their own target date fund based upon their lifespan and data. As we use the data initially to build on our current programs, all the way down to now, our next program will be where there's a massive industry in the life Tracking business, we do that to track insurers and policyholders once we acquire and own the policy, utilizing Med And then lastly, in the financial services industry, which we'll be talking about shortly, how you can personalize someone's financial plan specifically related to their lifespan. And that data is going to add into different verticals, but more importantly or even more so add to our currently core business of being able to understand and underwrite our own policyholders even better. Speaker 400:22:05Great. Thanks, Jay. Operator00:22:17A confirmation tone will indicate that your line is in the queue. The next question comes from the line of David Bastian with Kingdom Capital Advisors. Please proceed with your question. Speaker 400:22:29Hey, guys. Thanks for taking my question. I was curious if you could comment on the recent Significant increase in interest rates and how you guys are able to stay profitable despite what I've had shown to be pretty significant Decreases in the discounted future cash flows on your policies? Speaker 100:22:48Sure. Thank you for asking that. Our industry itself is essentially uncorrelated as an investment in the sense that it's a mortality driven contract and not affected by movements in relation to fixed income or equity. However, where interest rates can in fact impact us is in relationship to our own cost of capital and it speaks to why we went public in the first place to help mitigate some of that risk. Being public gives us the opportunity to over the long term lower our capital costs so that we can manage that more effectively. Speaker 100:23:22And What we see today is and I think that this is such an important piece to our business. We do sit at the heartbeat of our industry. What does that really mean? We're effectively the market And we originate new contracts every month to the tune of $15,000,000 to $20,000,000 per month of new capital that we could deploy. And that was reflective in our 2nd quarter results. Speaker 100:23:42When we talk about the growth of 88% on capital deployed, that's what we saw quarter over quarter. So a high interest rate environment, from our perspective actually puts us in a little bit of a sweet spot. Here's why. Policyholders in this environment are seeking liquidity. And now they're coming to us and understanding that their life insurance policy is an effective liquid option now for them that they maybe didn't realize before, so our originations go up. Speaker 100:24:09And in addition to that, as an alternative asset manager within our own portfolio, Being that it's an uncorrelated asset, essentially, there are significant amounts of institutional Capital that is trying to access this asset to get double digit type of discount rates and returns even in this interest rate environment because the underlying asset So from an interest rate perspective and volatility market perspective, where Abacus sits as the market maker is truly a sweet And I think that's reflective in what our Q2 was like. When you look at the growth in earnings, you look at the growth in net income and you look at the growth of originations. Speaker 400:24:51Got it. That's really helpful. Thank you. And then related to that, you guys have these warrants sitting out here. Do you guys view those as a source of capital that you're hoping to get exercised? Speaker 400:25:01Or are you hopeful that you'd be able to use the terms in there to be able to Speaker 100:25:15Our premise was we wanted to see how let's have a couple of earnings calls, let's get everyone very I think 1st and foremost, it's an education process on who Abacus is, what we do, people understanding this data that we have and how we're applying it to not just life insurance, but other areas. And then from there assess what's the plan of action for the warrants, but either is suitable for us. If assuming that the warrants fall into the money And that rewards the shareholders who have stayed with us in this process, terrific. If there's a plan that makes sense to where we would strategically purchase those or try to Are those off back and buy those off the balance sheet? We will certainly consider that as well. Speaker 100:26:02We're I think in addition to the warrants, we're looking at the float Very, very closely and we realize it and that's the issue with anybody who goes public via a SPAC is that you might have a smaller flow. And so in the same mindset of the warrants, we're thinking about when and how a secondary might look for us in the near future. So for us, it's just a matter of getting our information out first, getting investors very comfortable with our story And then exploring all those options sooner rather than later. Speaker 400:26:35Okay. And so given the market size, Do you feel like if you got the $150,000,000 plus from the warrants that you'd be able to quickly deploy that? Or what kind of time would you be looking at given how much of an increase that would be to your capital base? Speaker 100:26:50Yes, that's a great question. And the answer is yes, we would be able to deploy that very, very quickly. So Again, if you look at the origination capital deployed just in the Q2, keep in mind that that was with our own capital, right? Imagine what we could do with another $100,000,000 or $150,000,000 But if you just look at that number, that means we're deploying arguably about $20,000,000 a month in the second quarter. And so then you can kind of extend that math. Speaker 100:27:14If we stayed at that pace, right, which I think that we would probably increase that, but even at that pace, would take us less than 6 months to get that deployed. And what you touch on is something super important that everybody should understand. Where does that what's our use of funds for that? It's to buy this asset, right? We're not here trying to hire more employees and to do these things and to put into this growth model that doesn't produce revenue or income. Speaker 100:27:38We're going to put it right back into the asset that we're buying and put those assets on our balance sheet, right, effectively owning policies. And I think that should be music to your ears And how we deploy that capital, what it would be used for, which would ultimately lead to the growth of our business and company, grow revenues, grow income. Speaker 400:27:57Yes, that makes sense. Thank you so much. Operator00:28:03There are no further questions at this And now I'd like to turn the floor back over to Jay Jackson for any closing comments. Speaker 100:28:10Well, thank you again to everyone for taking the time to listen in today. We are Excited to continue to share our story and our story that has 19 consecutive years of positive net income, Terrific, ROIC, great ROE, and we're a growth company with a massive addressable market that we're just beginning to tap into With data and technology that gives us the opportunity to tap into these other verticals that you're going to start to see over the next 6 months and we'll continue to make this Easier and easier to tell for you, your investors and as investors and shareholders, we thank you for joining this journey with us. And we the 2nd quarter results, we're very excited about and we look forward to future earnings calls with you.Read moreRemove AdsPowered by